Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.14 USD | +3.36% | -0.64% | +14.77% |
Apr. 23 | Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
Apr. 23 | Transcript : Kiniksa Pharmaceuticals, Ltd., Q1 2024 Earnings Call, Apr 23, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.77% | 1.38B | |
+7.50% | 111B | |
+11.34% | 106B | |
-12.35% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-9.08% | 16.81B | |
+38.36% | 12.54B | |
-24.40% | 8.09B |
- Stock Market
- Equities
- KNSA Stock
- News Kiniksa Pharmaceuticals, Ltd.
- Kiniksa Pharmaceuticals' Shares Rise as Q2 Net Income, Revenue Advance